The Capital Investment Structure of the Medicine Sector in Bangladesh

Authors

  • Esrat Jahan Tithi Student, Department of Banking and Insurance, University of Dhaka, Dhaka, Bangladesh.
  • Abdullah Al Mobarak Student, Department of Banking and Insurance, University of Dhaka, Dhaka, Bangladesh.
  • Naznin Parvin Dental Surgeon, Mandy Dental College & Hospital, Dhaka, Bangladesh.
  • Abu Hanif Student, Department of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
  • Lokiat Ullah Physician, Entrepreneur & Human Rights Worker, Dhaka, Bangladesh.
  • Musfiqa Ashraf Associate Professor (Sociology), School of Social Sciences, Humanities and Languages (SSHL), Bangladesh Open University, Gazipur-1705, Bangladesh.
  • Nanziba Nawar Duti Global Public Health (Ongoing), United Kingdom.
  • Mohammad Abdullah Al Masood M.Pharm, Deputy Manager, Product Management Department (PMD), Biopharma Limited, Dhaka, Bangladesh.
  • Abdul Kaium International Business, United Kingdom.
  • Joynab Zaohara Student, Farnborough Sixth Form College, United Kingdom.

DOI:

https://doi.org/10.3329/medtoday.v37i2.83344

Keywords:

Capital Investment Structure, Pharmaceutical Industry, Bangladesh Medicine Sector, Debt-Equity Ratio, Return on Assets (ROA), Return on Equity (ROE), Long-Term Debt, Retained Earnings, Pharmaceutical Financing, Equity Financing, Capital Market, Foreign Direct Investment (FDI), Financial Management, Research and Development (R&D), Investment Strategies, Pharmaceutical Companies, Dhaka Stock Exchange (DSE), Regulatory Framework, Institutional Barriers.

Abstract

The capital investment structure of the medicine sector in Bangladesh plays a pivotal role in determining the industry's financial resilience, research capabilities, and global competitiveness. This study applies a mixed-methods research design to comprehensively analyze the capital composition, financing strategies, and investment challenges facing pharmaceutical companies operating in Bangladesh. Quantitative analysis is conducted on panel data of 10 leading firms from 2014 to 2023, focusing on debt-equity ratios, return on assets (ROA), return on equity (ROE), and long-term capital trends. Qualitative data from interviews with industry experts and financial officers provide insights into decision-making processes, risk management, and investor behavior. Findings reveal a significant preference for equity over debt, with many companies leveraging internal funding and public equity rather than bank loans or venture capital. Institutional barriers, high interest rates, and policy inconsistencies have discouraged debt financing and foreign direct investment (FDI). Additionally, regulatory constraints and a weak capital market infrastructure limit the expansion of investment opportunities in research and development (R&D). The study concludes with strategic recommendations including development of sector-specific credit instruments, enhancement of IPO mechanisms, incentivization of private equity and venture capital, and the creation of favorable regulatory frameworks. By aligning capital investment strategies with global best practices, Bangladesh’s medicine sector can achieve long-term financial sustainability and innovation-driven growth.

Medicine Today 2025, Vol.37 (2): 269-273

Downloads

Download data is not yet available.
Abstract
103
PDF
69

Downloads

Published

2025-07-30

How to Cite

Jahan Tithi, E., Al Mobarak, A., Parvin, N., Hanif, A., Ullah, L., Ashraf, M., … Zaohara, J. (2025). The Capital Investment Structure of the Medicine Sector in Bangladesh. Medicine Today, 37(2), 269–273. https://doi.org/10.3329/medtoday.v37i2.83344

Issue

Vol. 37 No. 2 (2025)

Section

Review Articles